Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation
- PMID: 7664468
- DOI: 10.1016/0009-8981(95)06044-x
Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation
Abstract
We report molecular genetic analysis of 11 Japanese patients with myophosphorylase deficiency (McArdle's disease). Four reported mutations, frequently observed in patients with McArdle's disease, in exons 1, 5, 14 and 17 were investigated. Seven patients out of 11 were homozygous for a single-codon deletion at codon 708/709 in exon 17 and one patient was heterozygous for a single-codon deletion with an unknown mutant allele. In contrast, the predominant mutation reported in US and UK patients (CGA to TGA at codon 49 in exon 1), accounting for 75% and 83% of the cases, respectively, was not found in any of the Japanese patients. Results suggest that the predominant mutation in Japanese patients is a single-codon deletion at codon 708/709 in exon 17 (found in 73% of our patients) and differs from the most common mutation in US or UK patients.
Similar articles
-
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).N Engl J Med. 1993 Jul 22;329(4):241-5. doi: 10.1056/NEJM199307223290404. N Engl J Med. 1993. PMID: 8316268
-
The molecular genetic basis of myophosphorylase deficiency (McArdle's disease).Muscle Nerve Suppl. 1995;3:S23-7. doi: 10.1002/mus.880181407. Muscle Nerve Suppl. 1995. PMID: 7603523
-
McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases.Hum Mol Genet. 1993 Aug;2(8):1291-3. doi: 10.1093/hmg/2.8.1291. Hum Mol Genet. 1993. PMID: 8401511
-
McArdle's disease-muscle glycogen phosphorylase deficiency.Biochim Biophys Acta. 1995 Aug 15;1272(1):1-13. doi: 10.1016/0925-4439(95)00060-h. Biochim Biophys Acta. 1995. PMID: 7662715 Review. No abstract available.
-
McArdle's disease with late-onset symptoms: case report and review of the literature.J Neurol Neurosurg Psychiatry. 1992 May;55(5):407-8. doi: 10.1136/jnnp.55.5.407. J Neurol Neurosurg Psychiatry. 1992. PMID: 1602316 Free PMC article. Review.
Cited by
-
Clinical utility gene card for McArdle disease.Eur J Hum Genet. 2018 May;26(5):758-764. doi: 10.1038/s41431-017-0070-6. Epub 2018 Jan 25. Eur J Hum Genet. 2018. PMID: 29371640 Free PMC article.
-
Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.J Neurol. 2007 Jun;254(6):797-802. doi: 10.1007/s00415-006-0447-x. Epub 2007 Apr 3. J Neurol. 2007. PMID: 17404776
-
McArdle Disease and Exercise Physiology.Biology (Basel). 2014 Feb 25;3(1):157-66. doi: 10.3390/biology3010157. Biology (Basel). 2014. PMID: 24833339 Free PMC article.
-
Molecular diagnosis of McArdle disease using whole-exome sequencing.Exp Ther Med. 2021 Sep;22(3):1029. doi: 10.3892/etm.2021.10461. Epub 2021 Jul 18. Exp Ther Med. 2021. PMID: 34373715 Free PMC article.
-
Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.Neuromuscul Disord. 2017 Nov;27(11):997-1008. doi: 10.1016/j.nmd.2017.06.004. Epub 2017 Jun 16. Neuromuscul Disord. 2017. PMID: 28967462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials